Efficacy analyses of a randomized phase III clinical trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in patients with advanced or recurrent gastric cancer refractory to prior S-1 chemotherapy.

Authors

null

Hitoshi Inagaki

Department of Surgery, Gifu Central Hospital

Hitoshi Inagaki , Kazuhiro Nishikawa , Kazumasa Fujitani , Naotoshi Sugimoto , Tadashi Shigematsu , Tohru Ishiguro , Akira Tsuburaya , Masato Nakamura , Atsushi Nashimoto , Takao Yamane , Makoto Yamada , Motohiro Imano , Shohei Iijima , Yoshio Oka , Masato Kataoka , Shuichi Hironaka , Hideaki Andoh , Satoshi Morita , Junichi Sakamoto , Toshimasa Tsujinaka

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

UMIN000002571

Citation

J Clin Oncol 31, 2013 (suppl 4; abstr69)

DOI

10.1200/jco.2013.31.4_suppl.69

Abstract #

69

Poster Bd #

B13

Abstract Disclosures